Joseph F. Knapp, MD

Internal Medicine – Cardiology

Education/Training
    Fellowship in Cardiology at the University of Arizona Health Sciences, Tucson, Arizona
    Residency in Internal Medicine at the University of Arizona Health Sciences, Tucson, Arizona
    Residency in Public Health at the University of Washington, Seattle, Washington
    M.D. Georgetown University School of Medicine, Washington, D.C.
    B.S. in Chemistry, Santa Clara University, Santa Clara, CA

Board Certification

National Board of Medical Examiners 1975
Internal Medicine 1978-Indefinite
Cardiovascular Diseases 1985-Indefinite

Research Interests
A focus on clinical outcomes and comparative effectiveness research in cardiovascular diseases.

Research Trials

Principal Investigator
dal-OUTCOMES
CRESCENDO
DalGenE

Sub-Investigator
ASPECT
EVEREST II/REALISM
VIRGO
COGENTUS
DIONYSOS
CURRENT-Oasis 7
COAPT
Reduce LAP-HF

Publications

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J. 2009 Dec;158(6):896-901.e3.

Colucci VJ, Knapp JF. Increase in international normalized ratio associated with smoking cessation. Ann Pharmacother. 2001 Mar;35(3):385-6.

Oury JH, Doty DB, Oswalt JD, Knapp JF, Mackey SK, Duran CMG. Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure. Ann Thorac Surg. 1998 Dec;66(6 Suppl):S153-4.